The Quality Control System Behind A Single Needle: Building A Quality Control System For Stereotactic Breast Biopsy

https://www.mayoclinic.org/tests-procedures/breast-biopsy/about/pac-20384812

In the field of breast diagnosis, there is a consensus: pathology is the gold standard, and biopsy is the source of that gold standard. The quality of stereotactic breast biopsy directly affects the accuracy of diagnosis and the direction of treatment for patients. Therefore, establishing a comprehensive quality management system is crucial.

I. Personnel Qualifications and Training System

1. Operating Physician: Must possess a radiologist or breast surgeon's attending physician title or above, and have completed training on no fewer than 50 stereotactic biopsy cases;

2. Pathologist: Should possess experience in breast pathology diagnosis and be familiar with the key points of slide preparation and interpretation of calcifications;

3. Technician Team: Responsible for equipment maintenance, image acquisition, and coordinate calculation, and required to participate in regular quality control assessments.

II. Equipment Management Standards

- Daily Quality Control: Check the flatness of the compression plate and the accuracy of the laser positioning light;

- Weekly Quality Control: Calibrate the stereotactic positioning system, controlling the error within ±1mm;

- Annual Maintenance: Comprehensive testing and software system updates by the manufacturer's engineers.

III. Three-Check System for Consumables Management

For critical consumables such as biopsy needles, strictly implement the following:

1. Incoming Inspection: Verify the product registration certificate, production batch number, and expiration date;

2. Pre-Use Inspection: Confirm that the packaging is intact, the needle tip is free of barbs, and the graduations are clear;

3. Post-Use Traceability: Record the needle model, usage, and patient information to achieve full traceability.

IV. Standardized Operating Procedures (SOPs)

Develop detailed SOP documents covering:

- Preoperative Assessment Process: Imaging indications, contraindication screening;

- Intraoperative Operating Standards: Anesthesia method, puncture angle, sample quantity;

- Postoperative Processing Process: Specimen labeling, fixative selection, and submission deadline.

V. Pathology-Imaging Comparison Mechanism

Establish a monthly multidisciplinary quality control meeting, focusing on the analysis of:

- False negative cases: Review the puncture process and identify the causes (e.g., needle deviation, insufficient sampling);

- Inconsistent cases: When pathological results do not match the imaging description, discuss the images together;

- Complication cases: Analyze the causes and optimize the operating procedures.

VI. Monitoring and Improvement of Quality Indicators

Core quality control indicators include:

Indicator Name Acceptance Standard Specimen Acceptance Rate ≥95% Pathological Diagnosis Conformity Rate ≥90% (compared with surgical pathology)
Complication Incidence Rate Hematoma <5%, Infection <1% Patient Satisfaction ≥90%

Statistical analysis of data is conducted quarterly, and improvement measures are developed for weak areas. For example, if a low detection rate of calcifications is found, the number of samples can be increased or a larger diameter biopsy needle can be used.

VII. Cultivating a Patient Safety Culture

The ultimate goal of quality management is to ensure patient safety. By implementing:

- Adverse event reporting system: encouraging medical staff to proactively report potential risks;

- Patient safety education: popularizing puncture knowledge and reducing unnecessary fear;

- Emergency drills: simulating the handling procedures for emergencies such as needle breakage and massive bleeding.

A high-quality biopsy needle, coupled with a rigorous quality control system, is essential to creating a solid defense line protecting breast health.